NEW YORK--(BUSINESS WIRE)--Recombine, Inc., a clinical genetic testing company dedicated to helping patients and providers make informed healthcare decisions, announced a partnership with Sequenom Laboratories, a wholly owned subsidiary of Sequenom, Inc. (NASDAQ:SQNM), a leading life sciences company, to expand access to Recombine’s CarrierMap test beyond the fertility and in-vitro fertilization (IVF) setting. Sequenom will market the test under the name HerediT® UNIVERSAL.
Help employers find you! Check out all the jobs and post your resume.
